Cleared Traditional

K982034 - E-FAX SYSTEM

K982034 is an FDA 510(k) clearance for E-FAX SYSTEM, manufactured by Blakbag, Ltd., Division of Coherent Systems. The device is a Class 2 Cardiovascular device with product code DXH cleared through the Traditional 510(k) pathway after a 254-day FDA review.

K982034 · Blakbag, Ltd., Division of Coherent Systems · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1999
Decision
254d
Days
Class 2
Risk

K982034 is an FDA 510(k) clearance for the E-FAX SYSTEM. Classified as Transmitters And Receivers, Electrocardiograph, Telephone (product code DXH), Class II - Special Controls.

Submitted by Blakbag, Ltd., Division of Coherent Systems (Houston, US). The FDA issued a Cleared decision on February 19, 1999 after a review of 254 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2920 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Blakbag, Ltd., Division of Coherent Systems devices

FDA 510(k) Submission Details - K982034

510(k) Number K982034 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 10, 1998
Decision Date February 19, 1999
Days to Decision 254 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
129d slower than avg
Panel avg: 125d · This submission: 254d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXH Device Classification - Class 2, Special Controls

Product Code DXH Transmitters And Receivers, Electrocardiograph, Telephone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2920
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXH Transmitters And Receivers, Electrocardiograph, Telephone

All 175
Devices cleared under the same product code (DXH) and FDA review panel - the closest regulatory comparables to K982034.
TELEMEDICINE 2000
K992164 · Card Guard Scientific Survival , Ltd. · Aug 1999
EVENTSTATION ECG TRANS-TELEPHONIC RECEIVING SYSTEM
K991211 · Reynolds Medical , Ltd. · Jul 1999
TELEMEDICINE 2000
K991307 · Card Guard Scientific Survival , Ltd. · Jun 1999
KING OF HEARTS EXPRESS II & KING OF HEARTS EXPRESS EZ II
K983626 · Alaris Medical Systems, Inc. · Feb 1999
PACEART HOME TRAK PLUS EASI EVENT RECORDER SYSTEM
K982090 · Paceart, Inc. · Jan 1999
FM DEMODULATOR-4 LEAD MODEL #8500-05 AND FM DEMODULATOR-12 LEAD MODEL # 8500-25
K982228 · Tz Medical, Inc. · Jan 1999